Newstral
Article
observer-reporter.com on 2015-04-22 04:59
Perrigo rejects $29B offer from generic drugmaker Mylan
Related news
- Perrigo rejects $29B offer from generic drugmaker Mylandothaneagle.com
- Perrigo rejects $29B offer from drugmaker MylanThe Salt Lake Tribune
- Mylan offers about $29B for rival generic drugmaker Perrigomonroenews.com
- Mylan makes $29B offer for Perrigoobserver-reporter.com
- Generic drugmaker Mylan offers to buy Perrigo for $205 per share, or $28.86BThe Salt Lake Tribune
- Mylan makes $29B bid for Perrigobizjournals.com
- Mylan offers about $29B for rival drugmakerThe Columbian
- Mylan makes $29B bid for rival drugmaker Perrigoold.seattletimes.com
- Mylan again boosts offer for drugmaker Perrigotriblive.com
- Mylan raises bid for fellow drugmaker Perrigotriblive.com
- Generic drugmaker Mylan offers to buy Perrigo for $29 billionHaaretz
- Mylan makes bid for Irish drugmaker Perrigo for $29 billionpost-gazette.com